source
- Werewolf and Ambros to tie the knot in $150M rare disease dealThe merger, which would create a new company bearing Ambros’ name, will help support development of Ambros' non-opioid painkiller for patients with debilitating limb injuries.BioSpace · 1h ago↗ source
- Heidi Overton nominated as FDA commissioner, seen as boost for psychedelics and non-opioid pain drugsPresident Donald Trump announced that he will nominate Heidi Overton, a current White House policy advisor, to serve as the next FDA commissioner pending Senate confirmation. Analysts say Overton’…